Best Life Sciences Companies in Scottsdale, United States
The 52 best Life Sciences companies in Scottsdale, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Anuncia Medical.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Scottsdale
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Anuncia Medical Developer of a neuro therapeutic device for cerebrospinal fluid (CSF) management | $15M | 22 mo ago | Series A | Elsa Abruzzo CEO & President | 2018 | — | — | — |
| 2 | Regenesis Provider of at-home non-drug pain relief solutions for patients | $13M | 181 mo ago | Series C | Tom Eisiminger CEO | 1996 | WordPressApple iCloud MailMicrosoft 365+14 | 10 patents Patents concentrated in chemistry & materials | 1 award |
| 3 | Nevoa Automating hospital disinfection with innovative fogging technology and solutions | $10M | 19 mo ago | Series B | Mike Hudson CEO | 2009 | — | 2 patents Chlorine-based antiviral disinfection and catalytic hydrocarbon oxidation technologies. | — |
| 4 | OrthoScan Mini C-arms for orthopedic imaging | $8M | 196 mo ago | Acquired | Nelson Mendes CEO & President | 2002 | WordPressApple iCloud MailMicrosoft 365+14 | 29 patents Intraoperative mini C‑arm X‑ray imaging systems with continuously adjustable collimation | 1 launch |
| 5 | Cold Plasma Medical Technologies Developer of cold plasma jet technology for the treatment of wounds | $7M | 115 mo ago | Seed | David J. Jacofsky Chief Executive Officer | 2007 | — | — | — |
| 6 | MakuCell Platform for regenerative medicine | $2M | 165 mo ago | Deadpooled | Michael Kahn Co-Founder | 2010 | — | — | — |
| 7 | LEAH Labs Developer of gene editing tools for dogs to fight against cancer | $1M | 33 mo ago | Seed | — | 2018 | — | — | — |
| 8 | Opedix Scientifically engineered apparel and gear designed to activate movement system | $500K | 132 mo ago | Seed | Kim Gustafson Founder | 2004 | — | 11 patents Ergonomic apparel providing hip, pelvic alignment and posture support for active wear | — |
| 9 | The Patient Company Developer of a patient transfer device for hospitals | $500K | 42 mo ago | Funding Raised | Ryan Peters Co-Founder | 2019 | WebflowTypekitGoogle Font API+18 | 3 patents Patient positioning/rotation devices and Medicare reimbursement facilitation for medical services | — |
| 10 | Geno Twin Developer of diagnosis & treatment solutions of diseases by using genome data science | $200K | 67 mo ago | Seed | Oliver Elliott Co-Founder | 2020 | — | — | — |
| 11 | NF1 Provider of online assessment of physical test and manufacture's supplements | $150K | 67 mo ago | Seed | Karim Amin Founder & Owner & President | 2017 | WordPressMySQLPHP+33 | — | — |
| 12 | Gemneo Bioscience Provider of single-cell genomic technology for diagnostic applications | $100K | 105 mo ago | Seed | Gavin Chandler CEO & Director | 2016 | — | — | — |
Top 12 Life Sciences companies in Scottsdale
#1
Series B · Scottsdale, Arizona · founded 2009 · 12 employees$10.3Mraised▾
Automating hospital disinfection with innovative fogging technology and solutions, dedicated to revolutionizing healthcare disinfection practices. They offer technology-based solutions that automate disinfection and cleaning, reducing hospital-acquired infections (HAIs) and improving patient safety. Their product line includes whole-room fogging technology, handheld foggers for between-case disinfection, and hypochlorous acid solutions. They aim to transform manual disinfection processes into highly effective, automated protocols, providing superior disinfection at a reduced cost. Their solutions enhance patient outcomes, lower healthcare costs, and increase hospital staff efficiency. They provide innovative solutions to a persistent problem in the healthcare industry, focusing on improving the quality of care and reducing the risk of infections. They offer a comprehensive approach to hospital disinfection, utilizing advanced technology and effective disinfection protocols.
- Dec 2024Series B$5.9M
- Nov 2019Series A$2.9M
- Nov 2018Seed$1.5M
#2
Series A · Scottsdale, Arizona · founded 2018 · 19 employees$14.6Mraised▾
Developer of a neuro therapeutic device for cerebrospinal fluid (CSF) management. The company offers "ReFlow" an implanted shunt system to restore CSF flow for the diagnosis, treatment, or follow-up of patients with ventricular catheter occlusions.
- Aug 2024Series A$13.9M
- Aug 2022Seed$3.4M
- Dec 2021Seed$427.5K
#3
Seed · Scottsdale, Arizona · founded 2018 · 7 employees$1.2Mraised▾
Developer of gene-editing tool for dogs to fight against cancer. The company helps in editing the immune T cells of the dog with Chimeric antigen receptors (CAR) to form CAR T cells, which target the B-cell lymphoma in canine cancer.
- Oct 2023Grant (prize money)$973.9K
- 2023Grant (prize money)$225K
- Mar 2022Grant (prize money)$337.4K
- Apr 2021Seed$270.1K
#4
Series C · Scottsdale, Arizona · founded 1996 · 57 employees$13.3Mraised▾
Provider of at-home non-drug pain relief solutions for patients. It offers electromagnetic shortwave diathermy therapy devices to help in pain management which includes Reprieve 60, Reprieve Duo, and Reprive.
- Jun 2011Series C$5.2M
- Jun 2007Series B$2.8M
- Jun 2005Series B$2.1M
- Apr 2002Series A$3.2M
#5
Acquired · Scottsdale, Arizona · founded 2002 · 148 employees$8.3Mraised▾
OrthoScan is a global medical device company which develops orthopedic imaging devices. First product in the imaging market was the OrthoScan HD Mini C-Arm for fluoroscopic imaging of the extremities in orthopaedic surgery and for digital diagnostic imaging in the office. Second product was the Mobile DI fluoroscope which enables orthopaedic imaging in a smaller, lightweight design ideal for clinical use and remote/rugged applications. Also offers training services and support. Was acquired by ATON in 2011
- Mar 2010Series B$825K
- Oct 2008Series B$7.5M
#6
Funding Raised · Scottsdale, Arizona · founded 2019 · 3 employees$499.5Kraised▾
Developer of a patient transfer device for hospitals. It offers a SimPull device for lateral patient transfer which helps in moving a patient from one flat surface to another.
- Jan 2023Conventional Debt$499.5K
#7
Seed · Scottsdale, Arizona · founded 2007$6.7Mraised▾
Developer of a novel medical device designed to pioneer a new field in the healthcare market. The company's device kills bacteria in wounds, including multidrug-resistant bacteria on contact by combining high-voltage electricity with a non-combustible gas, enabling medical professionals to improve the quality of patients' lives worldwide.
#8
Deadpooled · Scottsdale, Arizona · founded 2010$1.7Mraised▾
Maku Cell has developed a platform technology for use in anti-aging. They have developed a product that interacts with the wnt of wnt signaling pathways of the cell and in turn regulates the stem cells of the body affecting the overall aging process. It calls its skin care products as Renewnt.
- Oct 2012Seed$1.7M
#9
Seed · Scottsdale, Arizona · founded 2020 · 10 employees$200Kraised▾
Developer of diagnosis & treatment solutions of diseases by using genome data science. It provides a genome platform combination of genomics, artificial intelligence, and computational biology to address the traditional pathogen tests of multiple therapeutic conditions. It also provides solutions for microbiome characterization, immune characterization, and more.
- Dec 2020Seed$200K
#10
Seed · Scottsdale, Arizona · founded 2004 · 4 employees$500Kraised▾
Developer of fitness sports gear designed to aid in free body motion. The company specializes in incorporating garments for training that optimizes human physiology and motion, enabling users to perform more with less effort and perform efficiently with less wear and tear.
#11
Seed · Scottsdale, Arizona · founded 2017$150Kraised▾
NeuroForce1 provides an online assessment of physical tests and manufacturer's supplements. The data from the baseline assessment is utilized to develop an individualized program to address functional deficiencies. The company manufactures multicategory supplements with natural herbs as their main component.
- Nov 2020Seed$100K
- Feb 2020Seed$50K
#12
Seed · Scottsdale, Arizona · founded 2016$100Kraised▾
Developer of an immune cell profiling technology designed to provide more optimal cancer treatments and groundbreaking immunotherapies to help improve cancer outcomes. The company's cell profiling technology identifies each patient's unique tumor signature and suggests key immune elements to exploit during immunotherapy, enabling physicians to better understand and tailor treatments around individual patients' disease and immune responses.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.